Area of research
Molecular Biology · Rheumatology
Research interest
Research interests include Cancer research, Biology, Osteosarcoma, Gene knockdown, Ubiquitin, and Ubiquitin ligase.
Orally administered degradable nanoarmor-assisted probiotics for remodeling the gut microenvironment and treating osteoporosis
Reversal of <scp>MPPa</scp> ‐ <scp>PDT</scp> Resistance in Osteosarcoma by Targeting <scp>ROCK2</scp> ‐Mediated Autophagy
Deubiquitinase USP10 promotes osteosarcoma autophagy and progression through regulating GSK3β-ULK1 axis
<scp>USP22</scp> Promotes Osteosarcoma Progression by Stabilising β‐Catenin and Upregulating <scp>HK2</scp> and Glycolysis
Accelerating the healing of rotator cuff tear through comprehensive repair strategy based on bioactive Cu2O-Decorated MXene Nanosheet
Anterior knee pain as a potential risk factor for falls in older adults: insights from the osteoarthritis initiative data
E3 ubiquitin ligase TRIM29 promotes pancreatic cancer growth and progression via stabilizing Yes-associated protein 1
E3 ubiquitin ligase UBR5 promotes pancreatic cancer growth and aerobic glycolysis by downregulating FBP1 via destabilization of C/EBPα
FAT10 promotes the progression of bladder cancer by upregulating HK2 through the EGFR/AKT pathway
Ubiquitin-like protein FAT10 promotes osteosarcoma glycolysis and growth by upregulating PFKFB3 via stabilization of EGFR.
PubMed 2020cited by 24position: first
ROCK2 mediates osteosarcoma progression and TRAIL resistance by modulating O-GlcNAc transferase degradation.
PubMed 2020cited by 22position: first
Chondrocyte suppression is mediated by miR‐129‐5p via GDF11/SMAD3 signaling in developmental dysplasia of the hip
Ubiquitin-like protein FAT10 promotes osteosarcoma growth by modifying the ubiquitination and degradation of YAP1
ROCK2 promotes osteosarcoma growth and metastasis by modifying PFKFB3 ubiquitination and degradation